Abstract
Diabetes mellitus begins as a disorder of glucose metabolism that progressively compromises the function of virtually every organ system as the secondary complications inexorably develop. The quality of life for patients with diabetes is diminished by the consequences of these complications. Accelerated and aggressive atherosclerosis is the greatest cause of morbidity and mortality with diabetes, emphasizing the importance of determining underlying mechanisms. This review highlights the role of the multiligand receptor for advanced glycation endproducts (RAGE) and two of its ligands, advanced glycation endproducts (AGEs) and S100/calgranulins, in the pathogenesis of atherosclerosis associated with diabetes. The results of the studies reviewed herein suggest that RAGE is a potential therapeutic target for macrovascular disease in diabetes.
Similar content being viewed by others
References
The Diabetes Control and Complications Trial Research Group: The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993, 329:977–986.
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000, 342:381–389.
Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-converting-enzyme inhibition on nephropathy. N Engl J Med 1993, 329:1456–1462.
Andersen S, Tarnow L, Rossing P, et al.: Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000, 57:601–606.
Detre K, Lomberdero M, Brooks M, et al.: the effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Engl J Med 2000, 342:989–997.
Hafner S: Coronary heart disease in patients with diabetes. N Engl J Med 2000, 342:1040–1042.
Brownlee M: Advanced glycosylation in diabetes and aging. Ann Rev Med 1995, 46:223–234.
Brownlee M, King G: Endocrinology and Metabolism Clinics of North America, volume 25, 1996; 200–400.
Sell D, Monnier VM: Structure elucidation of senescence cross-link from human extracellular matrix: implication of pentoses in the aging process. J Biol Chem 1989, 264:21597–21602.
Reddy S, Bichler J, Wells-Knecht K, et al.: Carboxymethyllysine is a dominant AGE antigen in tissue proteins. Biochem 1995, 34:10872–10878.
Schmidt A-M, Yan S-D, Wautier J-L, Stern DM: Activation of RAGE: a mechanism for chronic dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489–497.
Araki N, Higashi T, Mori T, et al.: Macrophage scavenger receptor mediates the endocytic uptake and degradation of AGEs of the Maillard reaction. Eur J Biochem 1995, 227:408–415.
Vlassara H, Li YM, Imani F, et al.: Identification of Galectin-3 as a high affinity binding protein for AGEs: a new member of the AGE-Receptor complex. Molec Med 1995, 1:634–646
Schmidt AM, Yan S-D, Brett J, et al.: Regulation of human mononuclear phagocyte migration by cell surface binding proteins for AGEs. J Clin Invest 1993, 91:2155–2168.
Yan SD, Schmidt AM, Anderson GM, et al.: Enhanced cellular oxidant stress by the interaction of AGEs with their receptors/binding proteins. J Biol Chem 1994, 269:9889–9897.
Wautier JL, Zoukourian C, Chappey O, et al.: Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble RAGE blocks hyperpermeability. J Clin Invest 1996, 97:238–243.
Wautier JL, Wautier MP, Schmidt AM, et al.: AGEs on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci 1994, 91:7742–7746.
Park L, Raman K, Lee K, et al.: Suppression of accelerated diabetic atherosclerosis by sRAGE. Nat Med 1998, 4:1025–1031.
Schmidt A-M, Hasu M, Popov, D, et al.: RAGE has a central role in vessel wall interactions and gene activation in response to AGEs in the intravascular space. Proc Natl Acad Sci 1994, 91:8807–8811.
Neeper M, Schmidt AM, Brett J, et al.: Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998–15004.
Kislinger T, Fu C, Qu W, et al.: N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression. J Biol Chem 2000, 274:31740–31749.
Deora A, Win T, Vanhaesebroeck B, Lander H: A redox-triggered Ras-effector interaction: recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J Biol Chem 1998, 273:29923–29928
Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM: Activation of the receptor for advanced glycation endproducts triggers a p21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997, 272:17810–17814
Hofmann M, Drury S, Caifeng F, et al.: RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889–901
Taguchi A, Blood D, delToro G, et al.: Blockade of RAGE/amphoterin axis suppresses tumor growth and metastases. Nature 2000; (in press)
Collins T: Endothelial nuclear factor kB and the initiation of the atherosclerotic lesion. Lab Invest 1993, 68:499–508.
Li J, Schmidt A-M: Characterization and functional analysis of the promoter of RAGE. J Biol Chem 1997, 272:16498–16506.
Miyata T, Oda O, Inagi R, et al.: Beta-2-microglobulin modified with AGEs is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993;92:1243–1252.
Miyata T, Hori O, Zhang J, et al.: RAGE mediates the interaction of AGE-beta-2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 1996, 98:1088–1094.
Schafer B, Heizmann C: The S100 family of EF-hand calcium-binding proteins: functions and pathology. TIBS 1996;21:134–140.
Rammes A, Roth J, Boegeler M, et al.: Myeloid-related Protein (MRP) 8 and MRP 14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496–9502.
Huttunen H, Fages C, Rauvala H: RAGE-mediated neurite outgrowth and activation of NF-kB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919–19924.
Ridley A, Paterson H, Johnston C, et al.: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401–410.
Nobes C, Hall A: Rho, Rac and Cdc42 GTPases regulate the assembly of mulitmolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81:53–62.
Hall A: Rho GTPases and the actin cytoskeleton. Science 1998, 279:509–514.
Lander H, Tauras J, Ogiste J, et al.: Activation of RAGE triggers a MAP kinase pathway regulated by oxidant stress. J Biol Chem 1997, 272:17810–17814.
Lalla E, Lamster I, Huang L, et al.: Blockade of RAGE suppresses periodontitis-associated alveolar bone loss in diabetic mice. J Clin Invest 2000, 105:1117–1124.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, A.M., Stern, D. Atherosclerosis and diabetes: The rage connection. Curr Atheroscler Rep 2, 430–436 (2000). https://doi.org/10.1007/s11883-000-0082-4
Issue Date:
DOI: https://doi.org/10.1007/s11883-000-0082-4